FDA Clears AgenTus IND for Allogeneic iNKT Cell Therapy
Go back to FDA Clears AgenTus IND for Allogeneic iNKT Cell Therapy| AGENUS (NASDAQ: AGEN) | Delayed: 6.91 +0.41 (6.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.50 | 52 Week High | $7.49 | |||
| Open | $6.52 | 52 Week Low | $2.61 | |||
| Day High | $6.99 | P/E | N/A | |||
| Day Low | $6.51 | EPS | $-1.10 | |||
| Volume | 366,856 | |||||



